BAD overexpression inhibits cell growth and induces apoptosis via mitochondrial-dependent pathway in non-small cell lung cancer
Open Access
- 1 June 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Cell International
- Vol. 13 (1), 53-10
- https://doi.org/10.1186/1475-2867-13-53
Abstract
Background The pro-apoptotic Bcl-2 protein BAD initiated apoptosis in human cells and has been identified as a prognostic marker in non-small cell lung cancer (NSCLC). In this study, we aimed to explore the functions of BAD in NSCLC. Methods Overexpression of BAD was performed by transfecting different NSCLC cell lines with wild-type BAD. Cell proliferation, cell cycle, apoptosis, and invasion were characterized in vitro. Tumorigenicity was analyzed in vivo. Western blot was performed to determine the effects of BAD overexpression on the Bcl-2 family proteins and apoptosis-related proteins. Results Overexpression of BAD significantly inhibited cell proliferation in H1299, H292, and SPC-A1 but not in SK-MES-1 and H460 cell lines in vitro. BAD overexpression also reduced the tumorigenicity of H1299/SPC-A1 cell in vivo. However, no appreciable effects on cell cycle distribution and invasion were observed in all these cell lines. BAD overexpression also induced apoptosis in all cell types, in which process expression of mitochondrial cytochrom c (cyto-c) and caspase 3 were increased, whereas Bcl-xl, Bcl-2, Bax and caspase 8 expressions did not changed. These findings indicated that a mitochondrial pathway, in which process cyto-c was released from mitochondrial to activate caspase 3, was involved in BAD overexpression-mediated apoptosis. Conclusions Our data suggested that increased expression of BAD enhance apoptosis and has negative influence on cell proliferation and tumor growth in NSCLC. Bad is a new potential target for tumor interventions.Keywords
This publication has 31 references indexed in Scilit:
- Overexpression of Bcl-2–Associated Death Inhibits A549 Cell Growth In Vitro and In VivoCancer Biotherapy & Radiopharmaceuticals, 2012
- BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient SurvivalClinical Cancer Research, 2011
- BAD Contributes to RAF-mediated Proliferation and Cooperates with B-RAF-V600E in Cancer SignalingPublished by Elsevier BV ,2011
- Glucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growthEndocrine-Related Cancer, 2010
- Expression of the Bcl-2 Protein BAD Promotes Prostate Cancer GrowthPLOS ONE, 2009
- Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancerEuropean Journal Of Cancer, 2009
- Proapoptotic Bad and Bid Protein Expression Predict Survival in Stages II and III Colon CancersClinical Cancer Research, 2008
- Enzastaurin, a Protein Kinase Cβ Inhibitor, Suppresses Signaling through the Ribosomal S6 Kinase and Bad Pathways and Induces Apoptosis in Human Gastric Cancer CellsCancer Research, 2008
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001